Sched.com Conference Mobile Apps
DIA 2025 Global Annual Meeting
DIA 2025 Global Annual Meeting
Sign up
or
log in
to add sessions to your schedule and sync them to your phone or calendar.
Schedule
Speakers
Search
Menu
Schedule
Speakers
Search
Alison Maloney
Bayer , United States
Head of Regulatory Affairs North America
Lesley Maloney
Genentech, A Member of the Roche Group, United States
Regulatory Policy Lead
Raghav Mani
NVIDIA, United States
Director of Digital Health Products,
Raghav Mani
NVIDIA, United States
Director of Digital Health Products
Shweta Maniar
Google Cloud, United States
Director, Healthcare and Life Sciences Solutions
SM
Stephanie Manson
IND Directions, LLC, United States
VM
Valentina Mantua
FDA, United States
Associate Director of Regulatory Science, OND, CDER
Anabela Marcal
European Medicines Agency, Netherlands
EMA Liaison Official to the US FDA
Kwaku Marfo
IQVIA, Ghana
Africa Market Development Specialist
SM
Segundo Mariz
European Medicines Agency, Netherlands
JM
Joseph Markmann
Johnson&Johnson, United States
Principal Data Science Lead, Global Regulatory Affairs
Ingrid Markovic
United States
Kristi Martin
Camber Collective, United States
Director
Sarah Martin
Eli Lilly & Co., United States
Senior Director - Global Regulatory Policy (Oncology)
GM
Grace Matimba
Medicines Control Authority of Zimbabwe, Zimbabwe
Chief Regulatory Officer
Maria Mavris
European Medicines Agency, Netherlands
Patient Relations
Jennifer McCafferty
Merck, United States
Senior Vice President, Regulatory CMC and Quality Assurance
Laura Mccary-Bloss
Amgen, Inc., United States
Vice President Global Regulatory Affairs
Lorie McClain
Salesforce, United States
Distinguished, Strategic Solution Engineer
Neil McCullough
IQVIA, United States
Executive Vice President, Clinical Quality and Compliance
Michael McDonald
Health Products Regulatory Authority, Ireland
Programme Manager, Office of the Chief Executive
Niamh McGuinness
IQVIA, United States
Director, Pharma Solutions, IQVIA Applied AI Science
Mark McKenzie
EmVenio Research, United States
Chief Medical Officer
AM
Amanda McMannis
The Prostate Cancer Clinical Trials Consortium, United States
Associate Director, Clinical Operations
Lindsay McNair
Equipoise Consulting, United States
Principal Consultant
Melodi McNeil
AbbVie, United States
Director, Regulatory Affairs (Global Regulatory Lead, Oncology Early...
Carly McWilliams, MBA
Roche Diagnostics, United States
Head of Regulatory Policy
DM
Denise Meade
Verily, United States
Vice President, Life Sciences and MedTech
Christine Mears
Generate BioMedicines, United States
Executive Director, Portfolio Management
David Meats
Certara, United States
Director, Regulatory Services & Medical Affairs Management
Ann Meeker-O'Connell
FDA, United States
Director, Office of Clinical Policy
Doug Melton
Vertex, United States
Distinguished Research Fellow
Angela Men
The Whiteoak Group, Inc, United States
Chief Executive Officer
Timothe Menard
F. Hoffmann-La Roche Ltd, Switzerland
Global Head, Quality Excellence Digital | Bioethics Coach (Data...
Amber Meriwether
Astellas Pharma, United States
Corporate Strategy
Todd Mersch
Microsoft, United States
Consulting Leader
Anton Mihic
McKinsey & Company, United States
Partner
Alexis Miller
Merck & Co., Inc., United States
Head, Global Regulatory Policy and Intelligence
Bruce Miller
COPD Foundation, United States
Chief Scientific Officer
Yuki Miyatake
Eli Lilly Japan, Japan
Sr Manager
DM
David Moeny
FDA, United States
Acting Deputy Director, Office of Pharmacovigilance and Epidemiology,...
Korrey Monroe
North Carolina Community Health Center Association, United States
Program Manager
Carol Morales
Astellas, United States
Lead, Quality Management and Capabilities
Greg Morehouse
Abbvie, United States
Senior Manager, RA Device, Combination Products
Marcelo Moreira
ANVISA, Brazil
GENERAL MANAGER
Ben Moscovitch
Amazon Web Services, United States
Public Policy
Taraneh Mousavi
University of Maryland, Baltimore, United States
PhD Student
Florence Mowlem
Umotif, United Kingdom
Chief Scientific Officer
Katie Moy
Acadia Pharmaceuticals, United States
Associate Director, Medical Information & Review
David Mukanga
Bill & Melinda Gates Foundation, United States
Deputy Director, Africa Regulatory Systems
Saurabh Mukhopadhyay
Abbvie, United States
Research Fellow, Statistical Innovations
Theresa Mullin
FDA, United States
Associate Center Director - CDER
Erin Mulrooney
Daiichi Sankyo, Inc, United States
Director, Portfolio Management
AM
Alissa Mun
FDA, United States
Health Scientist Policy Analyst, OMP, CDER
GM
Greeshma Mundayat
Maxisit, United States
Solution Owner
Monica Munoz
FDA, United States
Division Director, Division of Pharmacovigilance-I, OSE, CDER
Ryan Murphy
ICON, United States
Associate Outcomes Researcher
Lindsey Murray
Critical Path Institute, United States
Executive Director, Rare Disease COA Consortium
Kiran Musunuru
University of Pennsylvania, United States
Professor of Medicine
Nancy Myers
Catalyst Healthcare Consulting, United States
CEO and Founder
Jane Myles
Decentralized Trials and Research Alliance, United States
Program Director
Joseph Nadglowski
Obesity Action Coalition, United States
President/Chief Executive Officer
Sridevi Nagarajan
Ayusarogya, United Kingdom
DIA Communities Lead for AI in Healthcare
Meera Nagaria
Johnson & Johnson, United States
Senior Data Scientist
Narayan Nair
FDA, United States
Associate Director Regulatory Affairs, Office of Biostatistics and...
Mehdi Najafzadeh
Medidata Solutions, United States
Senior Director
Kenichi Nakamura
National Cancer Center Hospital, Japan
Chief, Department of International Clinical Development
Sumati Nambiar
Johnson and Johnson, United States
Senior Director
Rohit Nambisan
Lokavant, Inc., United States
CEO
SRIVIDYA NARAYANAN
Northeastern University, United States
Student
Vidya Narayanaswamy
IPM, United States
Senior Consultant
Wassim Nashabeh
Genentech, A Member of the Roche Group, United States
Vice President, Global Head of Technical Regulatory Policy &...
Adil Nashed
Health Canada, Canada
Drug Specialist
Sharmin Nasrullah
Salesforce, United States
General Manager, Life Sciences, Clinical
Aliza Nathoo
F. Hoffmann-La Roche Ltd., Canada
Senior Director, Content Strategy
Nancy Ngum
AUDA-NEPAD, South Africa
Public Health Officer
Christiane Niederlaender
Parexel International, United Kingdom
Vice President, Technical
NN
Nikolay Nikolov
FDA, United States
Director, Office of Immunology and Inflammation, OND, CDER
Brittany Niland
Eli Lilly and Company, United States
Senior Director-Clinical Trials Foundation Community Based Research
Shinichi Noda
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Division Director, Division of Planning and Management, Office of...
Francisco Nogueira
Accumulus Synergy, United States
Chief Executive Officer
RN
Rebecca Noss
Noss Research Consulting, United States
President, Global Pharmacovigilance Consultant
Perla Nunes
Community Outreach and Clinical Research DEI Thought Leader, United States
Patient Advocate
Jude Nwokike
USP, United States
Vice President, Global Health & Manufacturing Services
BO
Brendan O'Leary
United States
Consultant
Teresa Oblak
Fortrea, United States
Senior Director, Regulatory Strategy
SO
Sean Ogle
SEI Inc., United States
Senior Consultant
Miyako Okayama
Otsuka Pharmaceutical, Co., Ltd., Japan
Regulatory Expert, Regulatory Technology & Operations Office,...
Evon Okidi
Medidata Solutions, A Dassault Systemes Company, United States
Senior Data Scientist
Ebere Okpara
University of Illinois Chicago, United States
PhD Candidate
Jimi Olaghere
United States
Patient Advocate
Adriane Alves de Oliveira
ANVISA, Brazil
Health Regulation Expert
SO
Susan Oliveria
Thermo Fisher Scientific, United States
Vice President, Global Head of Epidemiology and Scientific Affairs...
Rosemary Orciari
Pfizer, United States
Senior Director, Reg Intel, Policy and QMS Lead
AO
Anna Osinski
Biogen, Inc., United States
Associate Director, Development Unit Lead, Patient Centricity and...
Manuel Osorio
FDA, United States
Senior Scientist for Emerging Technologies, OD, CBER
Feisal Othman
Bristol Myers Squibb, United States
Benefit Risk Assessment Lead
Mercy Owusu-Asante
University of Hertfordshire, United Kingdom
Graduate Student, School of Life and Medical Sciences
Chelsea O'Connell
Amgen, United States
Director, Global Regulatory Policy & Intelligence
Catina O'Leary
Health Literacy Media, United States
President and Chief Executive Officer
William Palo
AbbVie, United States
Director, Safety Statistics
RP
Renata Parca
ANVISA, Brazil
Health regulatory specialist
Sudip Parikh
United States
Chief Executive Officer and Executive Publisher, Science Journals
SP
Sohyeon Park
KIDS, Korea, Republic of
pharmacist
Valerie Parker
Duke-Margolis Institute For Health Policy, United States
Assistant Research Director
Jaymin Patel
AESARA, United States
HEOR
MP
Mayur Patel
AstraZeneca, United States
Vice President, Oncology Therapy Area, Global Patient Safety
EP
Elisabetta Patorno
Brigham and Women's Hospital; Harvard Medical School, United States
Associate Professor of Medicine
Julie Patterson
National Pharmaceutical Council, United States
Senior Director of Research
Richard Pazdur
FDA, United States
Director, Oncology Center of Excellence, CDER
Y. Veronica Pei
FDA, United States
Acting Associate Director, Biomedical Informatics and Regulatory...
Michael Pelosi
Astellas, United States
Director, Quality Analytics
Ruonan Peng
University of California, Riverside, United States
Graduate Research Assistant
DP
Daniel Pereira
ANVISA, Brazil
Raphael Sanches Pereira
ANVISA, Brazil
General Manager of the Office for Medicines
Eleanor Perfetto
Consultant, United States
Independent Consultant
Vada Perkins
Boehringer Ingelheim, United States
Vice President, Global Head of Regulatory Intelligence & Policy
LP
Luciana Petcu
Takeda, United States
Senior Manager
Maryrose Petrizzo
Clinical Quality Assured,LLC, United States
President and Consultant
Yen Phan
University of Oxford, Ireland
Student
Carie Pierce
DIA, United States
Global Head of Growth & Business Development
Maria Cristina Mota Pina
AbbVie, United States
Head, Regulatory Policy for Emerging Markets -Japan and Australia
Luis Pinheiro
European Medicines Agency, Netherlands
Senior Epidemiology Expert, RWE, Data Analytics and Methods Taskforce
Neosho Ponder
Tigerlily Foundation, United States
National A.N.G.E.L. Lead
Elena Popa
Bayer, Switzerland
Chief of Staff, Global Regulatory Affairs
Caroline Pothet
European Medicines Agency, Netherlands
Head of advanced therapies and haemato-oncology
James Pound
Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
Group Manager - British Pharmacopoeia & Laboratory Services
Johann Proeve
Cyntegrity, Germany
Chief Scientific Officer
Stephen Pyke
Parexel, United Kingdom
Chief Clinical Data and Digital Officer
Kim Quaintance-Lunn
Alexion, United States
Vice President, Head of Regulatory Science and Execution
AR
Adriana Racolta
Pfizer Inc, United States
Director, Regulatory Affairs, Companion Diagnostics
Sophie Radicke
Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
Head of GPvP and Senior Pharmacovigilance Inspector
AR
Allison Radwick
U.S. Pharmacopeia, United States
Senior Regulatory and Policy Communications Manager
Mohit Raizada
IQVIA, India
Director - Signal Management Services
Aysha Rana
Spectra Medical/Northeastern University, United States
Regulatory Affairs Specialist
DR
Diogo Rao
Eli Lilly, United States
Chief Information Officer
CR
Chantelle Rein-Smith
Whitsell Innovations, Inc., United States
Principal Medical Writer and Consultant
Matthew Renda
Alexion, Astrazeneca Rare Disease, United States
Senior Director Medical Writing Operations
Linda Reuter
BRANY IRB, United States
Senior Director
SR
Sarah Rhee
Alexion Pharmaceuticals, Inc, United States
Vice President, Head of Global Regulatory Affairs
Kim Ribeiro
Boehringer Ingelheim, United States
Director Patient Experience & Engagement
Brandon Rice
Weave Bio, United States
CPO
Katrina Rice
eClinical Solutions, United States
Chief Delivery Officer, Biometrics Services
Kevin Richards
AstraZeneca, Canada
Senior Director, Clinical Quality
Nicole Richie
Genentech, United States
Vice President & Global Head Health Equity & Population...
AC
Amy Comstock Rick
FDA, United States
Director of Strategic Coalitions, Rare Disease Innovation Hub
Lia Ridout
N/A, United States
Patient Advocate
Donna Rivera
FDA, United States
Associate Director for Pharmacoepidemiology, Oncology Center of...
Amanda Roache
PhRMA, United States
Deputy Vice President, Science and Regulatory Advocacy
SR
Sarah Roberge
WCG Clinical, United States
IBC Chair, IBC Services
Sajida Roberson
Independent Consultant, United States
Business Transformation
Samantha Roberts
AstraZeneca, United States
Senior Director, Regulatory Intelligence
Matthew Robillard
AbbVie, United States
Senior Director, Regulatory Strategic Writing
Kelly Robinson
Health Canada, Canada
Director General, Pharmaceutical Drugs Directorate
PR
Paulette Robinson
Neurogene Inc., United States
Senior Director, Regulatory Affairs
WR
Warren Roche
Sanofi, Ireland
Statistician
Lesbeth Rodriguez
Bayer, United States
Director, Regulatory Affairs Policy and Science
Patrick Rodriguez
Duke-Margolis Institute For Health Policy, United States
Policy Analyst
Carla Rodriguez-Watson
Reagan-Udall Foundation for the FDA, United States
Director of Research
Ulrich Rohr
Swissmedic, Switzerland
Unit Head Clinical Review Hematology & Oncology
Maria Antonieta Roman
Novartis, Mexico
Head Regulatory Policy LaCan
Peter Ronco
Emmes, United States
CEO
Patricia Roselle
Sanofi, United States
Head of Patient Stakeholder Engagement
Len Rosenberg
Beat AML, a division of The Leukemia and Lymphoma Society, United States
Head of Clinical Operations
Elizabeth Rosenkrands-Lange
EMD Serono, Part of Merck KGaA, Darmstadt, Germany, United States
Senior Director/ Head of US Regulatory Scientific Policy
David Ross
AstraZeneca, United States
Senior Director, Regulatory Data and Submissions
Dawn Rotellini
National Bleeding Disorder Foundation, United States
Chief Operating Officer
Cynthia Rothblum-Oviatt
FDA, United States
Science Policy Analyst, Rare Disease Team, OND, CDER
Mark Rothmann
FDA, United States
Division Director, OTS, OB, CDER
Todd Rudo
Clario, United States
EVP, Chief Medical Officer
Lisa Ruiz
Abbvie, United States
VP, Regulatory Affairs Operations, CMC & Device
Andrea Russell
Northwestern University Feinberg School of Medicine, United States
Assistant Professor
PR
Patrick Ryan
Janssen Pharmaceuticals, Inc., United States
Vice President Observational Health Data Analytics
FS
Fatima Sabar
Bluenote AI, United States
President
AS
Arman Sabbaghi
Unlearn, United States
Head of Biostatistics Research
Arman Sabbaghi
Purdue University, United States
Associate Professor of Statistics
Budi Gunadi Sadikin
Ministry of Health, Indonesia
Minister
Leslie Sam
Leslie Sam and Associates, LLC, United States
President
Toshiharu Sano
MSD, Japan
Associate Vice President
Dandara Santana
ANVISA, Brazil
CMC reviewer
Daniele Sartori
Uppsala Monitoring Centre, Sweden
Senior Pharmacovigilance Scientist
Junko Sato
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Associate Executive Director
Patrick Saunders
Eli Lilly & Co., United States
Senior Director-Quality, Lilly del Caribe
SS
Scott Schell
Cognizant, United States
Chief Medical Officer
Anja Schiel
Norwegian Medical Products Agency (noma), Norway
Special Advisor, Lead Methodologist/Statistician; NoMA
Chris Schneiderman
Abbvie, United States
Director, Data & Digital Convergence Catalyst
SS
Silke Schoch
National Health Council, United States
Director, Research & Programs
Eric Schrock
OM1, United States
Chief Technology Officer
Carrie Scott
AbbVie Ltd, Portugal
Head, Global PV Compliance and Policy, Pharmacovigilance and Patient...
Eri Sekine
CMIC Co., Ltd, Japan
Executive Vice President Data Business
RS
Rohini Sen
AbbVie, United States
Director, HEOR
Ana Sengupta
Mirum Pharmaceuticals, Inc., United States
Director Regulatory Affairs CMC
Omar Serang
DNAnexus, United States
Chief Cloud Officer
Imran Shah
EMD Serono, United States
SVP & Head, Global Regulatory, R&D Quality and Safety (RQS)
Saad Shakir
ADROITVIGILANCE, United Kingdom
Pharmacovigilance Physician and Pharmacoepidemiologist
Saad Shakir
Drug Safety Research Unit, United Kingdom
Director
Raja Shankar
IQVIA, United Kingdom
Vice President, Machine Learning
Ana Sharma
Abivax, United States
Vice President, Global Head of Research and Development Quality...
JS
John Sharretts
FDA, United States
Director at Division of Diabetes, Lipid Disorders, and Obesity
AS
Anantha Shekhar
University of Pittsburgh, United States
Dean, School of Medicine
1
2
3
4
Share Modal
Share this link via
Or copy link
Copy
